Literature DB >> 7937907

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

M Sedegah1, R Hedstrom, P Hobart, S L Hoffman.   

Abstract

Immunization with irradiated sporozoites protects animals and humans against malaria, and the circumsporozoite protein is a target of this protective immunity. We now report that adjuvant-free intramuscular injection of mice with plasmid DNA encoding the Plasmodium yoelii circumsporozoite protein induced higher levels of antibodies and cytotoxic T lymphocytes against the P. yoelii circumsporozoite protein than did immunization with irradiated sporozoites. Mice immunized with this vaccine had an 86% reduction in liver-stage parasite burden after challenge with 5 x 10(5) sporozoites (> 10(5) median infectious doses). Eighteen (68%) of 28 mice that received two or three doses of vaccine were protected against challenge with 10(2) sporozoites, and the protection was dependent on CD8+ T cells. These studies demonstrate the utility of plasmid DNA immunization against a nonviral infection. By obviating the requirement for peptide synthesis, expression and purification of recombinant proteins, and adjuvants, this method of immunization provides an important alternative for rapid identification of protective B- and T-cell epitopes and for construction of vaccines to prevent malaria and other infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937907      PMCID: PMC44918          DOI: 10.1073/pnas.91.21.9866

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum.

Authors:  S Kumar; L H Miller; I A Quakyi; D B Keister; R A Houghten; W L Maloy; B Moss; J A Berzofsky; M F Good
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

2.  CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Authors:  W R Weiss; M Sedegah; R L Beaudoin; L H Miller; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  A rapid method for screening antibodies to Plasmodium yoelii liver stages by immunofluorescence.

Authors:  M Sedegah; M F Leef; S Matheny; R L Beaudoin
Journal:  J Parasitol       Date:  1987-12       Impact factor: 1.276

4.  Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

Authors:  H L Robinson; L A Hunt; R G Webster
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

5.  Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes.

Authors:  N D Pacheco; C P Strome; F Mitchell; M P Bawden; R L Beaudoin
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

6.  Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines.

Authors:  A A Lal; V F de la Cruz; J A Welsh; Y Charoenvit; W L Maloy; T F McCutchan
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

7.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

8.  In vivo testing of subunit vaccines against malaria sporozoites using a rodent system.

Authors:  A A Lal; V F de la Cruz; M F Good; W R Weiss; M Lunde; W L Maloy; J A Welsh; T F McCutchan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice.

Authors:  M Manthorpe; F Cornefert-Jensen; J Hartikka; J Felgner; A Rundell; M Margalith; V Dwarki
Journal:  Hum Gene Ther       Date:  1993-08       Impact factor: 5.695

10.  Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.

Authors:  S L Hoffman; D Isenbarger; G W Long; M Sedegah; A Szarfman; L Waters; M R Hollingdale; P H van der Meide; D S Finbloom; W R Ballou
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

View more
  88 in total

1.  A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.

Authors:  E D Franke; A Sette; J Sacci; S Southwood; G Corradin; S L Hoffman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice.

Authors:  S Kawabata; Y Terao; T Fujiwara; I Nakagawa; S Hamada
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Intralymphatic immunization enhances DNA vaccination.

Authors:  K J Maloy; I Erdmann; V Basch; S Sierro; T A Kramps; R M Zinkernagel; S Oehen; T M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies.

Authors:  C A Lobo; R Dhar; N Kumar
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.

Authors:  Lian-San Zhao; Shan Qin; Tao-You Zhou; Hong Tang; Li Liu; Bing-Jun Lei
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

6.  DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

Authors:  L Planelles; M C Thomas; C Alonso; M C López
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.

Authors:  John R Mascola; Anna Sambor; Kristin Beaudry; Sampa Santra; Brent Welcher; Mark K Louder; Thomas C Vancott; Yue Huang; Bimal K Chakrabarti; Wing-Pui Kong; Zhi-Yong Yang; Ling Xu; David C Montefiori; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.

Authors:  Ariane Rodríguez; Jaap Goudsmit; Arjen Companjen; Ratna Mintardjo; Gert Gillissen; Dennis Tax; Jeroen Sijtsma; Gerrit Jan Weverling; Lennart Holterman; David E Lanar; Menzo J E Havenga; Katarina Radosevic
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

9.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.

Authors:  S Kodihalli; H Goto; D L Kobasa; S Krauss; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.